
US drugs giant Pfizer on Sunday announced it had made a final improved bid for British competitor AstraZeneca, valuing the company at £69 billion ($117 billion). In a letter written from Pfizer chairman and chief executive officer Ian Read to AstraZeneca chairman Leif Johansson, the US giant said that Pfizer and AstraZeneca shareholders would own "approximately 73 percent and 27 percent, respectively, of the combined company. "The improved proposal values AstraZeneca today at approximately £69 billion," it added.
GMT 14:12 2018 Tuesday ,23 January
Oscar best director nomineesGMT 14:09 2018 Tuesday ,23 January
Oscar best actress nomineesGMT 14:06 2018 Tuesday ,23 January
Oscar best actor nomineesGMT 13:58 2018 Tuesday ,23 January
Oscar best foreign film nomineesGMT 20:03 2018 Monday ,22 January
Eurozone approves 6.7-bln-euro bailout tranche for GreeceGMT 20:00 2018 Monday ,22 January
Trump to travel to Davos as shutdown deal reached: W.HouseGMT 19:57 2018 Monday ,22 January
Democrats to vote to reopen US government: SchumerGMT 19:53 2018 Monday ,22 January
Afrin clashes kill 54 Syrian Kurd and pro-Turkey fighters: monitor
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor